martes, 25 de agosto de 2020

FDA finalizes penalties for trial sponsors, but critics say they fall short

FDA finalizes penalties for trial sponsors, but critics say they fall short

Cancer Briefing

STAT Plus: FDA finalizes penalties for clinical trial sponsors that don’t share data, but critics say they fall short

By ED SILVERMAN


JACQUELYN MARTIN/AP
“This seems to severely limit when and where the FDA plans to actually try and enforce the law,” said Nicholas DeVito of the University of Oxford's EBM Lab.

No hay comentarios: